Home Equities Score Bio-Path Holdings Inc. (BPTH) stock gains during current market trading. Here’s to...

Bio-Path Holdings Inc. (BPTH) stock gains during current market trading. Here’s to know why?

Bio-Path Holdings Inc. (NASDAQ: BPTH) stock surged by 8.76% in the current market trading. Bio-Path is a biotech firm working on DNAbilize, a new technique that has resulted in a pipeline of RNAi nanoparticle medicines that may be given by intravenous infusion.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Current Update

The US Patent and Trademark Office has awarded a new patent to BPTH for its BP1003 program, which is a novel liposome-incorporated oligodeoxynucleotide inhibitor against Signal Transduction and Activator of Transcription-3 (STAT3). “P-Ethoxy Nucleic Acids for STAT3 Inhibition,” according to the patent (US Patent No. 11,041,153).


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

The new patent expands on previous patents that cover the platform technology for DNAbilize, BPTH’s new RNAi nanoparticle medicines. DNAbilize is a patent-pending liposomal nanoparticle delivery and antisense technique that uses a basic intravenous transfusion to systemically distribute nucleic acid medicines all through the body.

In cancer cells, STAT3 is hyperactive. Cancer is characterized by tumor cells’ ability to grow uncontrolled, defy apoptosis, promote vascular development, and infiltrate distant organs. STAT3 is a gene regulator that controls the expression of genes implicated in cancer. Tumors’ capacity to elude immune monitoring and prevent elimination by the immune system has lately received widespread support in the cancer research community. At several levels, STAT3, which is a point of confluence for numerous oncogenic pathways, has emerged as a key modulator of tumor immune evasion.

Peter Nielsen, President, and CEO of Bio-Path Holdings stated,

Bio-increasing Path’s intellectual property collection remains to be a valuable asset, and the inclusion of this new patent adds to that important as they progress their newest pipeline product, BP1003. This mechanistic patent protects their position and emphasizes the uniqueness of BP1003’s ability to inhibit STAT3 which is a protein that has been found to be overexpressed in a number of complicated cancers, including pancreatic cancer, non-small cell lung cancer, and acute myeloid leukemia (AML), among others. BPTH is excited to go on with the development of BP1003 in pancreatic cancer, which they plan to start next year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

ImmunoPrecise Inc. (IPA) stock fell during pre-market. What’s the update?

ImmunoPrecise Inc. (NASDAQ: IPA) stock declined by 8.39% at last close while the IPA stock-price plunge by 4.87% in pre-market as well. ImmunoPrecise is...

ECMOHO Ltd. (MOHO) stock plunged during pre-market. Let’s see what’s happening?

ECMOHO Ltd. (NASDAQ: MOHO) stock gained by 7.05% at last close, while during pre-market MOHO stock has been seen declining by 7.75%. In China's...

Synthetic Biologics Inc. (SYN) stock plunged during pre-market. Here’s what you should know?

Synthetic Biologics Inc. (NASDAQ: SYN) stock gained by 8.09% at last close whereas the SYN stock price declines by 0.54% in the pre-market trading....

Related News

UXIN stock declines during current market trading. What’s driving it low?

Uxin Ltd. (NASDAQ: UXIN) stock declines by 3.41% during current market trading. In China, Uxin Limited is a prominent online used vehicle dealer with...

Synthetic Biologics Inc. (SYN) stock plunged during pre-market. Here’s what you should know?

Synthetic Biologics Inc. (NASDAQ: SYN) stock gained by 8.09% at last close whereas the SYN stock price declines by 0.54% in the pre-market trading....

Why did Atossa Therapeutics Inc. (ATOS) underperform on Thursday?

Atossa Therapeutics Inc. (ATOS) shares fell 5.38% in after-hours on Thursday, July 29, 2021, and closed the daily trading at $3.69 per share. Earlier...

Why Ardelyx Inc. (ARDX) stock price fluctuated on Thursday?

Ardelyx Inc. (ARDX) shares jumped 2.92% in after-hours on Thursday, July 29, 2021, and closed the daily trading at $1.76. Earlier in the regular...

Annovis Bio Inc. (ANVS) stock plunged during current market. Here’s the update

Annovis Bio Inc. (NASDAQ: ANVS) stock declined by 51.30% in the current market trading session. Annovis Bio based in Berwyn, Pennsylvania, is a clinical-stage...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam